Insider Stock Trading History of Sumeray Mark


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sumeray Mark since year 2005. The trader's CIK number is 1527134. At the time of this reporting, Sumeray Mark is the Chief Medical Officer of Aegerion Pharmaceuticals, Inc. . (stock ticker symbol AEGR). See this page for all insider trading activities at Aegerion Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Sumeray Mark since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-03-14 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2014-03-14 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 50.99 101,986
2014-02-14 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2014-02-14 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 63.83 127,660
2014-01-16 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 59.05 118,098
2014-01-16 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2014-01-02 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 1,000 13.01 13,010
2014-01-02 AEGR Aegerion Pharmaceuticals, Inc. Sale 1,000 70.82 70,815
2013-12-16 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2013-12-16 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 66.80 133,608
2013-12-02 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 3,000 13.01 39,030
2013-12-02 AEGR Aegerion Pharmaceuticals, Inc. Sale 3,000 70.71 212,138
2013-11-15 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2013-11-15 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 76.15 152,302
2013-11-01 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 3,500 13.01 45,535
2013-11-01 AEGR Aegerion Pharmaceuticals, Inc. Sale 3,500 83.56 292,474
2013-10-15 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2013-10-15 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 80.33 160,658
2013-10-07 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 3,500 13.01 45,535
2013-10-07 AEGR Aegerion Pharmaceuticals, Inc. Sale 3,500 93.47 327,141
2013-09-16 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2013-09-16 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 90.29 180,580
2013-08-16 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2013-08-16 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 88.97 177,938
2013-07-15 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,000 78.61 157,220
2013-07-15 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,000 13.01 26,020
2013-06-17 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 6,000 13.01 78,060
2013-06-17 AEGR Aegerion Pharmaceuticals, Inc. Sale 6,000 65.86 395,130
2013-05-15 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 6,000 13.01 78,060
2013-05-15 AEGR Aegerion Pharmaceuticals, Inc. Sale 6,000 47.32 283,932
2013-04-22 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 6,000 13.01 78,060
2013-04-22 AEGR Aegerion Pharmaceuticals, Inc. Sale 6,000 40.88 245,268

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sumeray Mark (Chief Medical Officer of Aegerion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.